01 4Nayzilam
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 31
2019 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 63
2020 Revenue in Millions : 31
Growth (%) : 119
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 83
2021 Revenue in Millions : 63
Growth (%) : 32
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 101
2022 Revenue in Millions : 83
Growth (%) : -17
LOOKING FOR A SUPPLIER?
